Cargando…
Identifying the hidden burden of allergic rhinitis (AR) in community pharmacy: a global phenomenon
BACKGROUND: Patients with allergic rhinitis often trivialise their condition, self-manage inappropriately, and would benefit from health care intervention. The primary point of health care contact for these self-managing allergic rhinitis patients is the community pharmacy. With the majority of alle...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696909/ https://www.ncbi.nlm.nih.gov/pubmed/29201385 http://dx.doi.org/10.1186/s40733-017-0036-z |
_version_ | 1783280530288017408 |
---|---|
author | Tan, Rachel Cvetkovski, Biljana Kritikos, Vicky Price, David Yan, Kwok Smith, Pete Bosnic-Anticevich, Sinthia |
author_facet | Tan, Rachel Cvetkovski, Biljana Kritikos, Vicky Price, David Yan, Kwok Smith, Pete Bosnic-Anticevich, Sinthia |
author_sort | Tan, Rachel |
collection | PubMed |
description | BACKGROUND: Patients with allergic rhinitis often trivialise their condition, self-manage inappropriately, and would benefit from health care intervention. The primary point of health care contact for these self-managing allergic rhinitis patients is the community pharmacy. With the majority of allergic rhinitis treatments being available for purchase over the counter, without health care professional contact, we know little about how the patients self-manage. This study aims to identify the burden of allergic rhinitis in the community pharmacy and to identify key opportunity for intervention. METHODS: Pharmacy customers, who purchased nasal treatment in a community pharmacy, were approached with a research-administered questionnaire that collected data on medical history, symptoms and products purchased for the treatment of nasal symptoms. RESULTS: Of the 296 participants, 69.9% self-managed with over-the-counter medications; with 68% experiencing allergic rhinitis symptoms and only 44.3% of this subgroup had a doctor’s diagnosis. Nasal congestion (73.6%) was most commonly experienced and oral antihistamines were most commonly purchased (44.3%), indicating a pattern of suboptimal management. A third of participants (36.5%) experienced moderate-severe symptoms, persistently, which impacted on their daily living. Medication selection was mainly based on pharmacy customers’ perceptions of medication effectiveness (47.6%). CONCLUSION: A majority of participants that self-selected over-the-counter medications have symptoms consistent with allergic rhinitis, with almost half not having received a diagnosis. Medication purchasing patterns suggest that sub-optimal therapeutic decisions made by participants, even when they are experiencing significant symptoms. This study uncovers the hidden burden of allergic rhinitis in the community pharmacy and a missed opportunity to intervene and refer if necessary. Patients need to be guided through appropriate treatment as this study showed that many should be referred to a medical practitioner. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s40733-017-0036-z) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5696909 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-56969092017-12-01 Identifying the hidden burden of allergic rhinitis (AR) in community pharmacy: a global phenomenon Tan, Rachel Cvetkovski, Biljana Kritikos, Vicky Price, David Yan, Kwok Smith, Pete Bosnic-Anticevich, Sinthia Asthma Res Pract Research BACKGROUND: Patients with allergic rhinitis often trivialise their condition, self-manage inappropriately, and would benefit from health care intervention. The primary point of health care contact for these self-managing allergic rhinitis patients is the community pharmacy. With the majority of allergic rhinitis treatments being available for purchase over the counter, without health care professional contact, we know little about how the patients self-manage. This study aims to identify the burden of allergic rhinitis in the community pharmacy and to identify key opportunity for intervention. METHODS: Pharmacy customers, who purchased nasal treatment in a community pharmacy, were approached with a research-administered questionnaire that collected data on medical history, symptoms and products purchased for the treatment of nasal symptoms. RESULTS: Of the 296 participants, 69.9% self-managed with over-the-counter medications; with 68% experiencing allergic rhinitis symptoms and only 44.3% of this subgroup had a doctor’s diagnosis. Nasal congestion (73.6%) was most commonly experienced and oral antihistamines were most commonly purchased (44.3%), indicating a pattern of suboptimal management. A third of participants (36.5%) experienced moderate-severe symptoms, persistently, which impacted on their daily living. Medication selection was mainly based on pharmacy customers’ perceptions of medication effectiveness (47.6%). CONCLUSION: A majority of participants that self-selected over-the-counter medications have symptoms consistent with allergic rhinitis, with almost half not having received a diagnosis. Medication purchasing patterns suggest that sub-optimal therapeutic decisions made by participants, even when they are experiencing significant symptoms. This study uncovers the hidden burden of allergic rhinitis in the community pharmacy and a missed opportunity to intervene and refer if necessary. Patients need to be guided through appropriate treatment as this study showed that many should be referred to a medical practitioner. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s40733-017-0036-z) contains supplementary material, which is available to authorized users. BioMed Central 2017-11-21 /pmc/articles/PMC5696909/ /pubmed/29201385 http://dx.doi.org/10.1186/s40733-017-0036-z Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Tan, Rachel Cvetkovski, Biljana Kritikos, Vicky Price, David Yan, Kwok Smith, Pete Bosnic-Anticevich, Sinthia Identifying the hidden burden of allergic rhinitis (AR) in community pharmacy: a global phenomenon |
title | Identifying the hidden burden of allergic rhinitis (AR) in community pharmacy: a global phenomenon |
title_full | Identifying the hidden burden of allergic rhinitis (AR) in community pharmacy: a global phenomenon |
title_fullStr | Identifying the hidden burden of allergic rhinitis (AR) in community pharmacy: a global phenomenon |
title_full_unstemmed | Identifying the hidden burden of allergic rhinitis (AR) in community pharmacy: a global phenomenon |
title_short | Identifying the hidden burden of allergic rhinitis (AR) in community pharmacy: a global phenomenon |
title_sort | identifying the hidden burden of allergic rhinitis (ar) in community pharmacy: a global phenomenon |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696909/ https://www.ncbi.nlm.nih.gov/pubmed/29201385 http://dx.doi.org/10.1186/s40733-017-0036-z |
work_keys_str_mv | AT tanrachel identifyingthehiddenburdenofallergicrhinitisarincommunitypharmacyaglobalphenomenon AT cvetkovskibiljana identifyingthehiddenburdenofallergicrhinitisarincommunitypharmacyaglobalphenomenon AT kritikosvicky identifyingthehiddenburdenofallergicrhinitisarincommunitypharmacyaglobalphenomenon AT pricedavid identifyingthehiddenburdenofallergicrhinitisarincommunitypharmacyaglobalphenomenon AT yankwok identifyingthehiddenburdenofallergicrhinitisarincommunitypharmacyaglobalphenomenon AT smithpete identifyingthehiddenburdenofallergicrhinitisarincommunitypharmacyaglobalphenomenon AT bosnicanticevichsinthia identifyingthehiddenburdenofallergicrhinitisarincommunitypharmacyaglobalphenomenon |